Shabbir Ansari: Rare F3 Missense Variants Markedly Impair Coagulation Initiation
Shabbir Ansari, Assistant Professor at University of Texas at Tyler School of Medicine, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Blood:
“Excited to share that our new paper in Blood is online!
We demonstrate that selected rare human F3 (tissue factor) missense variants markedly impair coagulation initiation via two distinct mechanisms: disruption of TF–FVIIa binding, or perturbation of a TF exosite required for efficient macromolecular substrate activation (Factors IX and X). Although these variants do not alter standard clinical coagulation assays, carriers exhibit reduced basal coagulation activation in vivo, supporting a previously unappreciated role for TF in supporting basal FVII activation in humans.
As an added bonus, one of the images from this study was selected for the journal’s cover image, recognizing the conceptual and mechanistic insights from this work. Many thanks to my postdoc mentor, Sol Schulman, co-authors, and collaborators for a fantastic team effort.”
Title: Human missense variants in F3 impair the initiation of blood coagulation
Authors: Shabbir A. Ansari, Marisa A. Brake, Nishtha Pathak, James T. Flaumenhaft, Jacob G. Ludington, Natasha Panwar, Ernest Turro, Sol Schulman
Read the Full Article on Blood
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology